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Abstract
Background: Myocardial infarction (MI) is the clinical manifestation of coronary heart disease that can be caused by
athesclerotic plaque rupture. However, the role of MI in influencing endothelial cells is still not clearly known,
especially in atheroma plaque development. The aim of this study was to determine the effect of MI in the inflammatory
processes occurring in the hypercholesterolaemic rat aorta and heart by measuring myeloperoxidase (MPO) levels.
Methods: Wistar rats were categorised into normal, normal–MI, hypercholesterolaemic and hypercholesterolaemic–MI
groups. Hypercholesterolaemia was induced in rats by feeding them with a high-cholesterol diet, followed by oral
administrations of cholesterol, cholic acid and propylthiouracil. The MI rat model was created by injecting isoproterenol
(intraperitoneal) 1 day before the animals were sacrificed. The success of the induction was confirmed based on a
significant increase in total cholesterol values compared to those in the normal group. The inflammatory condition was
determined by measuring the MPO levels using the dot blot method. Results: MPO expression was increased
significantly in the hypercholesterolaemic rats compared to that in the normal group. The highest aorta MPO expression
was observed in the hypercholesterolaemic–MI group. Both MI rats and hypercholesterolaemic rats showed a similar
increase in MPO expression in the heart (71.7% and 75.5%, respectively). However, the hypercholesterolaemic–MI rats
showed the highest MPO expression (119.59%). Conclusions: MI accelerates inflammation in the aorta of hypercholesterolaemic rats.
Keywords: atherosclerosis, hypercholesterolaemic, myeloperoxidase, myocardial infarction

such as total cholesterol, triglycerides, HDL and LDL.
High levels of total cholesterol, triglycerides and LDL,
as well as low levels of HDL, are among the factors that
can induce the formation AF atheroma plaques.

Introduction
Myocardial infarction (MI) can be caused due to genetic
factors, diseases and environmental reasons. Hypertension
and diabetes mellitus can increase the risk of coronary
heart disease. Smoking can also increase the prevalence
of MI. Other factors include lack of exercise, high
consumption of saturated fats and lack of consumption of
certain vitamins. High levels of low-density lipoprotein
(LDL) cholesterol and low levels of high-density
lipoprotein (HDL) cholesterol have been reported to be
consistently associated with the risk of cor onary heart
disease.1

Inflammatory conditions play a major role in stages of
atheroma plaque formation. Inflammatory mediators such
as oxidants and free radicals are produced by various cells
in the body as a mechanism of resistance to diseasecausing agents. Myeloperoxidase (MPO) is an enzyme
released by activated and degranulated polymerphonuclear
neutrophils and monocytes. MPO is released by leukocytes
under inflammatory conditions and catalyses the
production of some reactive oxidant species such as
hypochlorite acid (HOCl), which contribute towards
protection against microorganisms.3 MPO along with
other enzymes such as lipoxygenase can initiate lipid
oxidation in the subendothelial area of the blood vessel
wall. MPO also participates in endothelial dysfunction,
because MPO uses nitrogen oxide as a substrate. The most
important characteristic of MPO and its end product,
HOCl, is the ability to activate matrix metalloproteinases

Oxidised LDL mediates the transformation of macrophages to cholesterol-rich foam cells. If left untreated,
cloggings occurring in small and medium blood vessels
in the inferior extremity may result in loss of sensation
and gangrene (tissue death) in the legs. Atheroma plaque
formation in the blood vessels can cause heart attacks
and strokes.2 The diagnosis of hypercholesterolaemia
can be established through several blood parameters
40
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(MMPs) and deactivate MMP inhibitors, which further
weaken the fibrous cap and cause instability of the
atheroma plaque.4 Therefore, MPO may be considered
as one of the markers in the formation and development
of atheroma plaques. Patients with coronary heart disease
have been reported to show an increase in MPO levels
in the blood5. Therefore, MPO can be used to determine
disease progression of atheroma plaques and MI.
The role of MI in the development and rupture of
atheroma plaques is still not clear. Therefore, in this study,
the role of MI in the formation of atheroma plaques was
investigated, for which hypercholesterolaemia was
induced by orally feeding the test animals with food rich
in cholesterol, propylthiouracil (PTU), pure cholesterol
and cholic acid. Furthermore, MI was induced in the
animals through the administration of isoproterenol
intraperitoneally the day before sacrifice. MPO levels in
the aortic blood vessels and the heart of the animals
were determined using the dot blot method. The aim of
this study was to determine the effect of hypercholesterolaemia in the inflammatory process occurring in the
aorta and the heart under the condition of MI through
the measurement of MPO expression.

Methods
Materials. The following materials were used in this
study: high-cholesterol chow 10 kg (20 pieces of chicken
liver, 1 kg cow fat, 1 kg goat fat, 75 quail eggs, 20 duck
eggs, 3 kg wheat flour and 2 kg corn flour), normal
chow, cholic acid, pure cholesterol, PTU, vegetable oil,
aquadest, NaCl 0.9% solution, CMC-sodium, total
cholesterol kit (supplier PT. Rajawali Nusindo, Jakarta,
Indonesia), HDL kit (supplier PT. Rajawali Nusindo,
Jakarta, Indonesia), triglyceride kit (supplier PT. Rajawali
Nusindo, Jakarta, Indonesia), isoproterenol, liquid nitrogen,
Bradford reagent, PBS solution, 1% skimmed milk,
Tween 20, 1% Triton X-100, 0.1% SDS, 0.5 and 20 mM
EDTA, 1 mM PMSF, 100 and 150 mM NaCl, 1 M NaOH,
5 mM MgCl2, 10 mM Tris-HCl (pH 7.5), 100 mM TrisHCl (pH 9.5), standard BSA solution, 50 mg/mL BCIP
solution, 50 mg/mL NBT solution, DMF solution, MPO
(Bioss-USA) polyclonal primer antibody and anti-rabbit
IgG (whole molecule)–alkaline phosphatase-conjugated
(Sigma-Aldrich, St. Louis, MO, USA) secondary antibody.
Test Animals. Ethical approval was obtained from the
Ethics Committee for Animal Research, Bandung Institute
of Technology, with regard to protection and welfare of
the animals used in this study (No. 05/KEPHP-ITB/082016). The test animals were 22 male Wistar rats aged
10–12 weeks and weighing 200–350 g. The animals
were obtained from the Animal Laboratory of School of
Pharmacy, Bandung Institute of Technology. The test
animals were placed in cages under suitable environments
based on animal testing standards.
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Grouping of Test Animals. The test animals were
categorised into four groups with each group consisting
of five to six rats. Group one was the normal group that
was not provided any treatment, except normal feeding.
Group two was another normal group but with the
induction of MI the day before the isolation of the aorta
and the heart. Group three consisted of hypercholesterolaemic rats that were fed with food containing high
cholesterol and cholic acid, pure cholesterol and PTU.
Group four was the hypercholesterolaemia–MI (H-MI)
group, in which the rats underwent the induction of
hypercholesterolaemia through the administration of
high cholesterol as well as the induction of MI the day
before the isolation of the aorta and the heart.
Preparation of High-Cholesterol Feed. Hypercholesterolaemia was induced in the animals through the oral
administration of a high-cholesterol diet and water ad
libitum, as well as PTUPTU, pure cholesterol and cholic
acid. PTU 12.5 mg/kg BW/day was suspended in 0.3%
CMC-Na with aquadest as the solvent. Cholic acid 200
mg/kg BW/day and pure cholesterol 100 mg/kg BW/day
were dissolved in vegetable oil. All the three substances
were administered to the rats for 5 consecutive days
each week. The high-cholesterol feed composition was
prepared from 20 chicken livers, 1 kg cow fat, 1 kg goat
fat, 75 quail eggs, 20 duck eggs, 3 kg wheat flour and 2
kg corn flour. Cholesterol-rich feed was administered
for 85 days.
MI Animal Model. MI was induced in the animals
through the intraperitoneal administration of isoproterenol
150 mg/kg body weight in saline solution a day before
the animals were sacrificed.6,7
Collection of Rat Blood. Rat blood was collected for
the evaluation of lipid profile. Lipid profile analysis
included the measurement of total cholesterol, triglycerides, HDL and LDL. The lipid profiles of all animals
were evaluated at the end of the experiment. Only total
cholesterol was measured before induction, as well as 1
and 2 months after induction. Rat blood was collected
through lateral venous blood vessels in rat tails, while
the rats were positioned inside the restrainer. A total of
0.3 mL of blood was collected into Eppendorf tubes and
centrifuged for 5 min at 10,000 rpm. After centrifugation,
the serum component was collected and stored at −20 °C.
Quantification of Lipid Markers. The levels of total
cholesterol, triglycerides, and HDL were measured in
rat serum using commercially available kits according to
the manufacturer’s instructions. All kits were purchased
from PT. Rajawali Nusindo, Jakarta, Indonesia. LDL
cholesterol level was determined using the Friedewald
equation8 as follows:
LDL = Total Cholesterol − HDL − (Triglyceride/5)
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Plasma atherogenic index = Log [Triglyceride/HDL]
Isolation of Aorta and Heart. The test animals were
first sacrificed under CO2 gas. The aorta and the heart of
the animals were isolated in a cold state as soon as
possible to prevent protein degradation by protease. The
isolated aorta and the heart were placed at the base of an
Eppendorf tube for later immersion in liquid nitrogen.
Protein Identification Using Dot Blot. Into every 5 mg
of frozen aorta and heart, 300 µL of lysis buffer was
added. The lysis buffer consisted of 50 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 0.5 mM EDTA, 1% Triton X100, 0.1% SDS and 1 mM PMSF. The sample was then
homogenised using a sonicator for 5 min with a 30-s on–
off cycle. Samples were centrifuged at 10,000 rpm at 4 °C
for 5 min. The supernatant con-taining the total protein
was collected and stored at −20 °C.
Characterisation of MPO Proteins. Total protein
samples from the aorta and the heart, as much as 4 µg
each, were blotted on a nitrocellulose membrane. The
nitrocellulose membrane was then immersed in a
blocking solution (5% skimmed milk and 0.1% Tween
20 in PBS) for 30 min under shaking at room
temperature (25 °C) at low speed (75 rpm). Then,
primary MPO antibodies (1:1000) were added to the
blocking solution and incubated for 3 h in the shaking
incubator. After incubation, the nitro-cellulose
membrane was cleansed three times using TBS-T
solution, wherein the third cleansing was done for 5 min
in the shaking incubator. The TBS-T solution consisted
of 10 mM Tris-HCl, 150 mM NaCl, aquadest, and 0.1%
Tween 20. The nitrocellulose membrane was then
incubated with a secondary antibody in the blocking
solution (1:4000) for 1 h in the shaking incubator. Then,
the membrane was cleansed in the same manner.
Membrane visualisation was performed using NBT–
BCIP in an alkaline phosphatase buffer and protected
from light. NBT 3.3 mg was dissolved in 46.2 µL DMF
and 19.8 µL aquadest. BCIP 1.65 mg was dissolved in
33 µL DMF. The staining reaction was stopped by
adding 20 mM EDTA in TBS. The ImageJ V.1.43u
software was used for analysing the dot blot results.
Statistical Analysis. The results of the experiments
were analysed statistically using SPSS 21.0. Significant
differences between the control and the experimental
groups were assessed by ANOVA. p < 0.05 was
considered to be statistically significant.
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Results
Lipid Profile of Hypercholesterolaemic and MI Rats.
At the beginning of induction of hypercholesterolaemia,
the average total cholesterol level of all the test groups
was 73.36 mg/dL. The mean value was not much
different from the average total cholesterol levels in
each group, as shown in Figure 1. The statistical
analysis showed that the total cholesterol level of the
normal group was not significantly different from the
total cholesterol levels at all time points of observation.
A similar result was observed for the total cholesterol
level of the normal–MI group (Figure 1). However, the
total cholesterol level of the hypercholesterolaemic and
the hypercholesterolaemic–MI groups increased significantly compared to those in the normal and the
normal–MI group, respectively. The increase in total
cholesterol levels of the hypercholesterolaemic and the
hypercholesterolaemic–MI groups was observed until 3
months of induction (Figure 1).
Regarding the levels of triglycerides and HDL, there
was no significant difference among all the test groups
(p > 0.05) compared with the normal group, as shown in
Figures 2 and 3, respectively. These data indicate that the
inductions had not affected the levels of triglycerides
and HDL of the test animals till 3 months. However, the
LDL levels were significantly increased in the hypercholesterolaemic and the hypercholesterolaemic–MI groups
compared to those in the normal group (Figure 4).
Regarding the atherogenic index of each group, both the
hypercholesterolaemic and the hypercholesterolaemic–
MI groups showed a significant increase compared to that
in the normal group (Figure 5). This finding suggests
that the rat groups in which hypercholesterolaemia was
induced had a high risk for cardiovascular disease compared
with the rats without hypercholesterolaemia induction.
Total Cholesterol Level (mg/dL)

Determination of Plasma Atherogenic Index. The
plasma atherogenic index is a logarithm of molar
concentration ratio (mmol/L) of plasma triglycerides to
HDL used to predict the cardiovascular risk. The
following equation9 was applied to determine the
plasma atherogenic index:
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Figure 1. Changes in total cholesterol levels of Normal (N),
Normal–Infarction (NI), Hypercholes-terolaemia
(H) and Hypercholesterolaemia–Myocardial
Infarction (HI) Groups. Before Induction (T0),
one, two and third months after induction (T1,T2,
T3). All Values are expressed as Mean ± SD. The
statistical calculation was performed using
ANOVA, followed by LSD; n = 5–6; *p < 0.05
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Figure 2. The triglyceride profile of Normal (n), Normal–
Infarction (ni), Hypercholesterolaemia (h) and
Hypercholesterolaemia–Myocardial Infarction (hi)
groups at the third month after induction. All
values are expressed as Mean±SD. The statistical
calculation was performed using anova, followed
by LSD; n = 5–6; *p < 0.05
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MPO Levels in the Aorta and the Heart of Hypercholesterolaemic and MI Rats. In the present study,
the MPO level was further determined in the aorta
(Figure 6) and the heart (Figure 7) of the rat models. It
was observed that high cholesterol induction could
significantly increase the MPO level in the aorta (Figure
6), but not in the heart (Figure 7), of rats compared to that
in the normal group. Concomitant hypercholesterolaemia
and MI led to a higher MPO level compared to that with
hypercholesterolaemia alone in the aorta and the heart
of both rat models.
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Figure 3. The HDL Levels of Normal (N), Normal–Infarction
(NI), Hypercholesterolaemia (H) and Hypercholesterolaemia–Myocardial Infarction (HI) groups after
3 months of induction with high cholesterol food.
the statistical calculation was performed using
ANOVA, followed by LSD; n = 5–6; *p < 0.05

NI

Figure 5. The Plasma Atherogenic Index of Normal (N),
Normal–Infarction (NI), Hypercholesterolaemia
(H) and Hypercholesterolaemia–Myocardial
Infarction (HI) groups after 3 months of
induction with high cholesterol food. All Values
are Expressed as Mean±SD. The statistical
calculation was performed using ANOVA,
followed by LSD; n = 5–6; *p < 0.05
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Figure 4. The LDL levels of Normal (N), Normal–Infarction
(NI), Hypercholesterolaemia (H) and Hypercholesterolaemia–Myocardial Infarction (HI) groups at
the third month after induction. All values are
expressed as Mean±SD. The statistical calculation
was performed using anova, followed by LSD; n =
5–6; *p < 0.05
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Figure 6. The Analysis of Mpo Expression in The Rat Aorta
Using The Dot Blot Method. The Quantification
of Mpo Expression in The Aorta of Normal (n),
Normal–Infarction (ni), Hypercholesterolaemia (h)
and Hypercholesterolaemia–Myocardial Infarction
(hi) Groups Using The Imagej Software. All
Values Are Expressed as Mean±SD. The
Statistical Calculation Was Performed Using
Anova, Followed by LSD; n = 5–6; *p < 0.05
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150

reducing the synthesis of thyroid hormones released by
the thyroid gland. One of the roles of thyroid hormone
is the activation of LDL receptors.11 Administration of
PTU may further decrease the expression of LDL
receptors, so that the circulating LDL level in the blood
increases.12 HDL is anti-atherogenic and thus can remove
cholesterol from cells, inhibit LDL oxidation, promote
endothelial repair, improve endothelial function, possesses
anti-thrombotic and anti-inflammatory tendencies and
inhibits monocyte attachment to the endothelium.13
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Figure 7. The analysis of MPO expression in the rat heart
using the dot blot method. The quantification of
MPO expression in the heart of normal (N),
normal–infarction (NI), hypercholesterolaemia
(H) and hypercholesterolaemia–myocardial
infarction (HI) groups using the ImageJ software.
All values are expressed as Mean±SD. The
statistical calculation was performed using
ANOVA, followed by LSD; n = 3–4 *p < 0.05.

The association between the risk of coronary artery
disease, high levels of LDL cholesterol and low HDL
cholesterol levels has been widely investigated. High
triglyceride levels are known to be associated with the
increasing incidence of cardiovascular disease and the
increasing amount of small dense LDL. The ratio
between triglycerides and HDL has been used as a
strong predictor for MI.14 In the present study, high
cholesterol administration increased the total cholesterol
and LDL levels and had no effect on triglyceride and
HDL levels, suggesting that the induction for increasing
the risk of coronary artery disease was successful.

Discussion
This study investigated the role of MI in the inflammatory
processes occurring in the aorta and the heart of hypercholesterolaemic rats by measuring the MPO level. It was
observed that MI significantly increases the inflammatory
status of the hypercholesterolaemic rat aorta. Overall,
the results of this study suggest that concomitant MI and
hypercholesterolaemia might lead to a faster atheroma
plaque formation.
In this study, first, the formation of atheroma plaques in
male Wistar rats was investigated through the induction
of hypercholesterolaemia. Hypercholesterolaemia has
been known to be a risk factor for the development of
atheroma plaques. Because total cholesterol was used as
the primary parameter in this study for creating the
high-cholesterol model animals, only the total cholesterol
level was measured each month. Other lipid profiles
were evaluated at the end of the induction to determine
the atherogenic index. Furthermore, MPO level was used
for measuring the inflammatory status upon induction
with high cholesterol and/or MI.
The induction of hypercholesterolaemia was performed
for 3 months exogenously, which was accomplished
through high cholesterol feed and 100 mg/kgBB cholesterol in vegetable oil, and endogenously by induction
with 200 mg/kg BW of cholic acid in vegetable oil and
PTU 12.5 mg/kg BW in aquadest. Cholic acid is one of
the major bile acids in the body; its administration
increases the absorption of exogenous cholesterol by
inhibiting cholesterol conversion to bile acids.10 This
inhibition will lead to an increase in cholesterol levels
and a decrease in cholesterol elimination. PTU works by
Makara J. Health Res.

It is known that a high cholesterol level induces inflammation in the adipose tissue15 and the vasculature.16
MI causes inflammation in the heart,17 however, its effect
on the vasculature is unknown. The present study showed
that MI induces systemic inflammation in both the heart
and the vasculature. Concomitant hypercholesterolaemia
and MI accelerates inflammation, which will accelerate
atheroma plaque formation.
This study implies a pharmacological knowledge of MI
contribution to the inflammatory status of the aorta and
the heart of hypercholesterolaemic rats. A limitation of
this study is that the inflammatory condition was
determined by measuring the MPO level using the dot
blot method. In the future, MPO protein level must be
measured using the western blot method. However, the
dot blot results can be used for predicting the western
blot results. Furthermore, a histopathological analysis of
the aorta and the heart is required to determine the effect
of high cholesterol level and/or isoproterenol administration on the aorta and the heart tissue. Furthermore,
since this study was conducted on rats, it is unknown
whether the results can be extrapolated to humans.

Conclusions
This study demonstrated that high cholesterol induction
in male Wistar rats significantly affected the expression
of MPO in the aorta, and the presence of the MI
condition accelarated the inflammation in the aorta.
Meanwhile, the presence of the MI condition in the
heart of male Wistar rats significantly affected the
expression of MPO and was aggravated by the presence
of high cholesterol levels.
April 2018 | Vol. 22 | No. 1
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